Multifunctional, High-level Cytokine-producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection Against Mycobacterium Tuberculosis Aerosol Challenge in Mice

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2008 Sep 20

PMID 18802099

Citations 167

Authors

Emily K Forbes

Clare Sander

Edward O Ronan

Helen McShane

Adrian V S Hill

Peter C L Beverley

Elma Z Tchilian

Affiliations

Soon will be listed here.

Abstract

Boosting bacillus Calmette-Guérin (BCG)-primed mice with a recombinant adenovirus expressing Mycobacterium tuberculosis Ag 85A by different administration routes has very different effects on protection against aerosol challenge with M. tuberculosis. Mice boosted intradermally make very strong splenic CD4 and CD8 Th1 cytokine responses to Ag 85A, but show no change in lung mycobacterial burden over BCG primed animals. In contrast, intranasally boosted mice show greatly reduced mycobacterial burden and make a much weaker splenic response but a very strong lung CD4 and CD8 response to Ag 85A and an increased response to purified protein derivative. This effect is associated with the presence in the lung of multifunctional T cells, with high median fluorescence intensity and integrated median fluorescence intensity for IFN-gamma, IL-2, and TNF. In contrast, mice immunized with BCG alone have few Ag-specific cells in the lung and a low proportion of multifunctional cells, although individual cells have high median fluorescence intensity. Successful immunization regimes appear to induce Ag-specific cells with abundant intracellular cytokine staining.

Citing Articles

Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: a roadmap for scientific advancement.

Sallard E, Aydin M Front Cell Infect Microbiol. 2024; 14:1388222.

PMID: 38988815 PMC: 11234472. DOI: 10.3389/fcimb.2024.1388222.

Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.

Davies M, Biryukov S, Rill N, Klimko C, Hunter M, Dankmeyer J Front Immunol. 2024; 15:1397579.

PMID: 38835755 PMC: 11148226. DOI: 10.3389/fimmu.2024.1397579.

Immunogenicity and protective efficacy of Ag85A and truncation of PstS1 fusion protein vaccines against tuberculosis.

Zeng L, Ma X, Qu M, Tang M, Li H, Lei C Heliyon. 2024; 10(5):e27034.

PMID: 38463854 PMC: 10920368. DOI: 10.1016/j.heliyon.2024.e27034.

Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal.

Hoseinpour R, Hasani A, Baradaran B, Abdolalizadeh J, Salehi R, Hasani A Heliyon. 2024; 10(4):e26193.

PMID: 38404880 PMC: 10884459. DOI: 10.1016/j.heliyon.2024.e26193.

Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination.

Silver R, Xia M, Storer C, Jarvela J, Moyer M, Blazevic A Nat Commun. 2023; 14(1):8507.

PMID: 38129388 PMC: 10739751. DOI: 10.1038/s41467-023-44136-8.

References

Julia V, Hessel E, Malherbe L, Glaichenhaus N, OGarra A, Coffman R . A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity. 2002; 16(2):271-83. DOI: 10.1016/s1074-7613(02)00276-5. View

Mogues T, Goodrich M, Ryan L, LaCourse R, NORTH R . The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med. 2001; 193(3):271-80. PMC: 2195922. DOI: 10.1084/jem.193.3.271. View

Goonetilleke N, McShane H, Hannan C, Anderson R, Brookes R, Hill A . Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol. 2003; 171(3):1602-9. DOI: 10.4049/jimmunol.171.3.1602. View

Masopust D, Vezys V, Usherwood E, Cauley L, Olson S, Marzo A . Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol. 2004; 172(8):4875-82. DOI: 10.4049/jimmunol.172.8.4875. View

Wang J, Santosuosso M, Ngai P, Zganiacz A, Xing Z . Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J Immunol. 2004; 173(7):4590-7. DOI: 10.4049/jimmunol.173.7.4590. View

Phillpotts R, Brooks T, Cox C . A simple device for the exposure of animals to infectious microorganisms by the airborne route. Epidemiol Infect. 1997; 118(1):71-5. PMC: 2808774. DOI: 10.1017/s0950268896007157. View

Cassidy J, Bryson D, Pollock J, Evans R, Forster F, Neill S . Early lesion formation in cattle experimentally infected with Mycobacterium bovis. J Comp Pathol. 1998; 119(1):27-44. DOI: 10.1016/s0021-9975(98)80069-8. View

Wang J, Thorson L, Stokes R, Santosuosso M, Huygen K, Zganiacz A . Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol. 2004; 173(10):6357-65. DOI: 10.4049/jimmunol.173.10.6357. View

Santosuosso M, Zhang X, McCormick S, Wang J, Hitt M, Xing Z . Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol. 2005; 174(12):7986-94. DOI: 10.4049/jimmunol.174.12.7986. View

10.

Galkina E, Thatte J, Dabak V, Williams M, Ley K, Braciale T . Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest. 2005; 115(12):3473-83. PMC: 1288831. DOI: 10.1172/JCI24482. View

11.

Romano M, DSouza S, Adnet P, Laali R, Jurion F, Palfliet K . Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine. 2006; 24(16):3353-64. DOI: 10.1016/j.vaccine.2005.12.066. View

12.

Zammit D, Turner D, Klonowski K, Lefrancois L, Cauley L . Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity. 2006; 24(4):439-49. PMC: 2861289. DOI: 10.1016/j.immuni.2006.01.015. View

13.

Etchart N, Baaten B, Andersen S, Hyland L, Wong S, Hou S . Intranasal immunisation with inactivated RSV and bacterial adjuvants induces mucosal protection and abrogates eosinophilia upon challenge. Eur J Immunol. 2006; 36(5):1136-44. DOI: 10.1002/eji.200535493. View

14.

Johnson L, Gough J, Spencer Y, Hewinson G, Vordermeier M, Wangoo A . Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis. Vet Immunol Immunopathol. 2006; 111(3-4):219-29. DOI: 10.1016/j.vetimm.2006.01.016. View

15.

Rodrigo Mora J, von Andrian U . T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006; 27(5):235-43. DOI: 10.1016/j.it.2006.03.007. View

16.

Betts M, Nason M, West S, De Rosa S, Migueles S, Abraham J . HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-9. PMC: 1895811. DOI: 10.1182/blood-2005-12-4818. View

17.

Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z . Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect Immun. 2006; 74(8):4634-43. PMC: 1539608. DOI: 10.1128/IAI.00517-06. View

18.

Santosuosso M, McCormick S, Roediger E, Zhang X, Zganiacz A, Lichty B . Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J Immunol. 2007; 178(4):2387-95. DOI: 10.4049/jimmunol.178.4.2387. View

19.

Kursar M, Koch M, Mittrucker H, Nouailles G, Bonhagen K, Kamradt T . Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol. 2007; 178(5):2661-5. DOI: 10.4049/jimmunol.178.5.2661. View

20.

Agrewala J, Brown D, Lepak N, Duso D, Huston G, Swain S . Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J Biol Chem. 2007; 282(9):6106-15. DOI: 10.1074/jbc.M608266200. View